Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook







Sex determination test successful at just seven weeks

15 August 2011

By Rose Palmer

Appeared in BioNews 620

A simple blood test for pregnant women can accurately predict the sex of a fetus at seven weeks, much earlier than conventional techniques, new research has found. A systematic review and meta-analysis examined the results of 57 earlier studies that included more than 6,500 pregnancies.

The blood test was accurate 94.8 percent of the time when predicting between seven and 12 weeks that the mother is carrying a boy and 98.9 percent of the time for girls. Tests using urine or taken before seven weeks' gestation were unreliable.

The non-invasive test detects fetal DNA in the mother's blood to see whether it is a girl or boy. Conventional techniques can typically detect gender later in gestation. For example, CVS, ultrasound and amniocentesis are usually done at 10 weeks, 13 weeks and 16 weeks respectively.

The test has been sold privately in several countries for a few years, including the UK. Despite the prior absence of a formal assessment, it has been incorporated into routine clinical care in countries such as the Netherlands, the UK, France and Spain.

The study authors said the blood tests could be a breakthrough for women at risk of having babies with gender-linked disorders, such as haemophilia, which typically affects men. The availability of this reliable non-invasive alternative could reduce the increased risk of miscarriages associated with amniocentesis and CVS, says TIME magazine.

The results of the study, however, should be generalised with caution as the research did not include tests sold directly to consumers, Associated Press reported.

Testing conditions can vary from lab to lab, said Dr Joe Leigh Simpson, a genetics professor at Florida International University who was not involved in the research.  The test also raises ethical concerns about deliberate sex selection of embryos, TIME reports.

'I would have a lot of difficulties offering such a test just for gender identification. Gender is not an abnormality', said Dr Lee Shulman, chief of clinical genetics at Northwestern Memorial Hospital in Chicago. 'My concern is this is ultimately going to be available in malls or shopping centres'.

'If there's a serious or life threatening genetic problem with the fetus, I understand people will want to end this pregnancy and start again', said Professor Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania. 'But when you're talking about picking a baby's sex, doctors shouldn't offer the test, companies shouldn't offer it, and we should tell people that it's not a good reason to have an abortion'.

The research was published in the Journal of the American Medical Association (JAMA).

 

SOURCES & REFERENCES
Time | 10 August 2011
 
Daily Mail | 10 August 2011
 
CBS News | 10 August 2011
 
Boy or girl? A simple test raises ethical concerns
Associated Press | 10 August 2011
 
WebMD | 11 August 2011
 
JAMA | 10 August 2011
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

03 September 2012 - by Ayesha Ahmad 
Dr Jeffrey Steinberg, a British IVF specialist who is now director of a pair of private clinics in the USA has claimed that dozens of couples see him every year to select the sex of their babies... [Read More]
23 January 2012 - by Dr Rebecca Robey 
A test has been developed to determine the sex of a fetus from only five weeks old. The test relies on a blood sample from the mother and therefore carries no risk to the child... [Read More]
14 November 2011 - by Dr Amy Strange 
If you could design your child right down to the smallest detail, what characteristics would you pick? This is the choice that Dr and Mrs Klaesson face in Peter James' latest novel, when they visit Dr Dettore, a renegade scientist who offers couples designer babies... [Read More]
12 September 2011 - by Vardit Ravitsky 
An up-and-coming technology will soon allow genetic testing of a fetus with a simple maternal blood test early in the first trimester of the pregnancy by isolating cell-free fetal DNA in the mother's plasma. Currently, obtaining reliable diagnostic genetic information requires invasive testing with Chorionic Villus Sampling (CVS) or amniocentesis. Both carry a risk of miscarriage and are performed between weeks 10 and 20 of the pregnancy... [Read More]

28 March 2011 - by Stevienna de Saille 
The use of pre-implantation genetic diagnosis (PGD) for sex selection has proven extremely controversial in the UK, where the procedure is illegal unless medically justified to avoid producing a child with a sex-linked genetic disorder, such as Duchenne muscular dystrophy. One reason often given for the restrictions is the fear that the technology will be used mainly to select male embryos... [Read More]
21 February 2011 - by Antony Blackburn-Starza 
A Liverpool hospital has said it will investigate allegations that one of its doctors had apparently offered to make arrangements for an undercover reporter posing as a prospective patient to undergo a sex-selection procedure for family balancing abroad... [Read More]
14 December 2009 - by Dr Charlotte Maden 
Scientists have found that a single gene maintains femininity in adult mice, and that when it is switched off they develop male features. The findings may help understand sex disorders in children or premature menopause in women.... [Read More]
08 December 2008 - by Evelyn Harvey 
By Evelyn Harvey: A new method for early detection of genetic diseases in unborn babies using a simple blood test can detect the inherited condition beta-thalassemia, according to a study published in Proceedings of the National Academy of Sciences. Although the technique, which analyses cell free fetal DNA (cffDNA) present... [Read More]
16 June 2008 - by Dr Zuzana Deans and Dr Ainsley Newson 
Dr Phillipa Brice's accompanying commentary highlights how non-invasive testing of free fetal DNA (ffDNA) in pregnancy could transform women's experiences of antenatal screening and prenatal diagnosis. NIPD is already available for foetal sex, rhesus D blood type and some Mendelian conditions such as achondroplasia, with tests for aneuploidy detection and... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation

Good Fundraising Code

Find out more about the Progress Educational Trust by downloading our brochure HERE